PDL BioPharma (PDLI) Reports Q2 EPS of $0.39
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q2 EPS of $0.39, versus $0.03 reported last year. Revenue for the quarter came in at $143.8 million, versus $21 million reported last year.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
